Phloretin cytoprotection and toxicity

Area of Science:

• Pharmacology
• Toxicology
• Drug Discovery

Background:

• Phloretin (Phl), a flavonoid, exhibits cytoprotective properties like free radical scavenging.
• Phl's potential therapeutic applications in pathogenic processes and drug toxicity prevention have been proposed.
• Acetaminophen (APAP) overdose is a significant cause of drug-induced liver injury.

Purpose of the Study:

• To evaluate the hepatoprotective effects of Phl against APAP-induced liver injury in a mouse model.
• To determine the dose- and route-dependent toxicity and efficacy of Phl.
• To investigate the protective mechanisms of Phl and its pharmacophores.

Main Methods:

• Administration of Phl via intraperitoneal (i.p.) and oral routes in a mouse model of APAP overdose.
• Assessment of APAP-induced lethality and hepatotoxicity.
• In vitro studies using isolated mouse hepatocytes and cell-free systems to examine protective mechanisms.

Main Results:

• Phl exhibited a bimodal effect; high i.p. doses were lethal, while lower doses provided modest hepatoprotection.
• Oral administration of Phl did not prevent APAP-induced hepatotoxicity and showed significant lethality at high doses.
• Phl pharmacophores, 1,3,5-trihydroxyacetophenone (PG) and 2',4',6'-trihydroxyacetophenone (THA), demonstrated protective effects in isolated hepatocytes.
• Polyphenol protectants inhibited glutathione depletion by the APAP metabolite N-acetyl-p-benzoquinone imine (NAPQI).

Conclusions:

• Phl demonstrated significant toxicity in APAP overdose models, limiting its therapeutic potential.
• The pharmacophores THA and PG are promising candidates for developing new therapeutic agents.
• Further research into THA and PG may lead to novel treatments for liver injury.